Loading patent…
AssigneesNational University Corporation Nagoya University, Life Science Institute, Inc.
InventorsYoshiaki Sato, Toshihiko Suzuki, Shinobu Shimizu, Masaaki Mizuno, Masahiro Hayakawa, Mari Dezawa
Estimating the term…
The present invention addresses the problem of providing a novel use of pluripotent stem cells (Muse cells) for medical purposes in regenerative medicine. The present invention provides a cell preparation and a pharmaceutical composition both for ameliorating and treating perinatal brain damage including learning disability and motor disability, each of the cell preparation and the pharmaceutical composition containing SSEA-3-positive pluripotent stem cells isolated from a mesenchymal tissue collected from a living body or cultured mesenchymal cells. The cell preparation according to the present invention relies on a mechanism that Muse cells are administered to a subject having the above-mentioned damage to cause the engraftment of the Muse cells in a damaged brain tissue, thereby ameliorating and treating the damage.
A cell preparation for amelioration and/or treatment of perinatal brain damage, comprising pluripotent stem cells positive for SSEA-3 isolated from mesenchymal tissue of or cultured mesenchymal cells.
Dependencies are inferred from the claim text.